FLUORINE F-18
LOE ApproachingNDAINTRAVENOUSINJECTABLEPriority Review
Approved
Feb 1972
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 4d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Fluorine F-18 is a positron-emitting radioisotope used as a tracer in positron emission tomography (PET) imaging to visualize metabolic processes in the body. It is administered intravenously and forms the basis for various PET radiopharmaceuticals used in oncology, neurology, and cardiology. The drug enables real-time visualization of disease at the molecular level rather than treating disease directly.
LOE Approaching
As an aging diagnostic agent approaching loss of exclusivity, GE HealthCare faces moderate competitive pressure (30% intensity) with likely contraction in brand-dedicated team headcount and shift toward imaging platform support roles.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Fluorine F-18 careers at GE HealthCare align with diagnostic and manufacturing excellence rather than commercial growth; roles emphasize operational stability, regulatory compliance, and technical expertise. This product offers depth in manufacturing science and diagnostic infrastructure but limited upside in commercial leadership or launch-phase brand building.
Diagnostic Product Manager
Worked on FLUORINE F-18 at GE HealthCare? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.